By Suanne Bender
The DRUGS Act — the Domain Reform for Unlawful Drug Sellers Act, H.R.6352;S.3399— would rob Americans of one of the only avenues for safe and affordable prescription medications: licensed international pharmacies.
What the DRUGS Act proposes is wrong; and it will hurt millions of people at risk of blood clots, hypertension, COPD and other common chronic conditions that, if not treated with safe and affordable drugs, will land us in hospitals and even morgues.
The special interests backing the DRUGS Act claim that the bill would address illegal sales of opioids online; however, the bill fails to even mention the words opioids or fentanyl. Instead, the bill targets “non-domestic” pharmacies — pharmacies that millions of Americans depend on for importation of safe and affordable medications.
The special interests backing the DRUGS Act do not represent citizens in need of these drugs, they represent pharmaceutical giants like Pfizer, Amgen, Gilead, Eli Lilly, Merck, Takeda, and many others. The DRUGS Act backers are funded and led by board members from PhRMA and big pharmaceutical companies. In fact, DRUGS Act supporter NABP took $1 million from Purdue Pharma, the maker of the highly addictive opioid painkiller OxyContin. These big pharma front groups backing the DRUGS Act have made a habit of shamelessly exploiting the opioid crisis to attack prescription importation from international pharmacies.